This is in line with previous clinical studies where E-cadherin expression in HCC patients’ tumour samples without cirrhosis and in hepatocellular adenoma was similar to that in normal liver samples27, thus reiterating the diversity in E-cadherin responses based on the stages and pathological severity of HCC. Here, CDH1 is linked to hepatocellular adenoma.